Article Figures & Data
Figures
- Figure 1.
Immunocytochemical detection of (A) S100B and (B) fibroblast growth factor 7 (FGF-7) in primary Schwann cells (SCs) isolated from rat sciatic nerves. The positive staining indicates that these SCs are S100B-positive and express FGF-7 (×10).
- Figure 2.
Fold changes (FC) in expression of fibroblast growth factor 7 (FGF-7), myelin basic protein (MBP), and peripheral myelin protein 22 (PMP-22) relative to untreated controls (Con) after 24-hour treatment with forskolin (Fsk), transforming growth factor beta 1 (TGFB), or transforming growth factor beta 1 + forskolin (T/F). Expression of FGF-7 and MBP significantly decreased with TGFB and T/F treatments (n=3, P<0.05).
- Figure 3.
Fold changes (FC) in expression of fibroblast growth factor 7 (FGF-7), myelin basic protein (MBP), and peripheral myelin protein 22 (PMP-22) relative to untreated controls (Con). Schwann cells were stimulated with transforming growth factor beta 1 (TGF-β1) + forskolin (T/F) alone or with T/F and LY2109761 (T/F+I), a TGF-β receptor type I/II (TβR1/II) inhibitor, for 6 hours (n=3). Blocking of TβR1/II decreased the effect of T/F treatment on FGF-7 expression (P<0.05).
In this issue
Jump to section
Cited By...
- No citing articles found.